日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Pegylated liposomal doxorubicin plus carboplatin versus paclitaxel plus carboplatin as first-line therapy for epithelial ovarian cancer (CGCS-04): a multicenter, randomized clinical trial

聚乙二醇化脂质体阿霉素联合卡铂与紫杉醇联合卡铂作为上皮性卵巢癌一线治疗方案的比较（CGCS-04）：一项多中心随机临床试验

期刊:Therapeutic Advances in Medical Oncology
影响因子:4.2
doi:10.1177/17588359261420402
Shen, Yuanming; Tu, Nalan; Kong, Beihua; Xia, Bairong; Zou, Yonghui; Yin, Rutie; Li, Qingshui; Yue, Ying; Kang, Shan; Wang, Ke; He, Liping; Wang, Shixuan; Meng, Yuanguang; Qu, Pengpeng; Huang, Xianghua; Guo, Ruixia; Yan, Ping; Pan, Mei; Cheng, Wenjun; Lou, Ge; Wang, Zehua
肿瘤
肿瘤免疫
卵巢癌
发表日期：2026
文献求助 收藏

A multicenter, prospective, non-interventional drug intensive monitoring study of olaparib in a large real-world Chinese patient cohort with ovarian cancer (DIM-OC)

一项针对中国卵巢癌真实世界患者队列的大型真实世界奥拉帕尼药物强化监测多中心、前瞻性、非干预性研究（DIM-OC）

期刊:Journal of Ovarian Research
影响因子:4.2
doi:10.1186/s13048-025-01924-8
Wang, Li; Xie, Lingling; Li, Qingshui; Shen, Yang; Wang, Huaying; Sun, Li; Yang, Hongying; Cao, Dongyan; Li, Haiying; Lin, Bei; Chen, Qionghua; Guo, Ruixia; Lou, Ge; Liu, Ziling; Shen, Yuanming; Feng, Weiwei; Zhang, Ping; Zhou, Jianwei; Wang, Xipeng; Wang, Yue; Shen, Zhen; Xue, Fengxia; Ma, Liguo; Tu, Chunhua; Yang, Yingjie; Cheng, Wenjun; Zhang, Yi; Kang, Shan; Li, Congzhu; Wen, Hongwu; Wu, Xin; Luo, Xiping; Yin, Rutie; Lin, Zhongqiu
肿瘤
肿瘤免疫
卵巢癌
发表日期：2025
文献求助 收藏

FGF21 modulates immunometabolic homeostasis via the ALOX15/15-HETE axis in early liver graft injury

FGF21 通过 ALOX15/15-HETE 轴调节早期肝移植损伤中的免疫代谢稳态

期刊:Nature Communications
影响因子:14.7
doi:10.1038/s41467-024-52379-2
Xinyu Yang #, Hao Chen #, Wei Shen #, Yuanming Chen #, Zuyuan Lin, Jianyong Zhuo, Shuai Wang, Modan Yang, Huigang Li, Chiyu He, Xuanyu Zhang, Zhihang Hu, Zhengxing Lian, Mengfan Yang, Rui Wang, Changbiao Li, Binhua Pan, Li Xu, Jun Chen, Xuyong Wei, Qiang Wei, Haiyang Xie, Shusen Zheng, Di Lu, Xiao X
代谢
免疫
Mouse
FGF21
发表日期：2024
文献求助 收藏

Evaluation of secondary cytoreduction surgery in platinum-resistant ovarian cancer patients within three-line recurrent: a multicenter, randomized controlled study

对铂耐药性卵巢癌三线复发患者进行二次细胞减灭术的评估：一项多中心随机对照研究

期刊:Journal of Gynecologic Oncology
影响因子:3.7
doi:10.3802/jgo.2024.35.e22
Chen, Tingting; Xu, Junfen; Xia, Bairong; Wang, Hui; Shen, Yuanming
细胞生物学
肿瘤
肿瘤免疫
卵巢癌
发表日期：2024
文献求助 收藏

Serum hsa_circ_0007534 as a diagnostic biomarker for ovarian cancer

血清hsa_circ_0007534作为卵巢癌的诊断生物标志物

期刊:American Journal of Translational Research
影响因子:1.6
doi:10.62347/KHAK2629
Cao, Mingyue; Gu, Yunchao; Lv, Beidi; Liu, Shouqian; Shen, Yuanming
肿瘤
肿瘤免疫
卵巢癌
发表日期：2024
文献求助 收藏

Comparison of the safety between cervical conization and hysterectomy for patients with cervical adenocarcinoma in situ

比较宫颈锥切术与子宫切除术治疗原位宫颈腺癌患者的安全性

期刊:Journal of Gynecologic Oncology
影响因子:3.7
doi:10.3802/jgo.2023.34.e8
Liu, Jingjing; Wang, Yu; Wan, Xiaoyun; Zou, Jian; Zhu, Yedan; Lv, Weiguo; Shen, Yuanming
肿瘤
肿瘤免疫
发表日期：2023
文献求助 收藏

Efficacy of lymph node dissection on stage IIICr of cervical cancer before CCRT: study protocol for a phase III, randomized controlled clinical trial (CQGOG0103)

宫颈癌 IIICr 期患者在接受同步放化疗前行淋巴结清扫术的疗效：一项 III 期随机对照临床试验的研究方案 (CQGOG0103)

期刊:Journal of Gynecologic Oncology
影响因子:3.7
doi:10.3802/jgo.2023.34.e55
He, Misi; Guo, Mingfang; Zhou, Qi; Tang, Ying; Zhong, Lin; Liu, Qing; Fan, Xiaomei; Zhao, Xiwa; Zhang, Xiang; Chen, Gang; Shen, Yuanming; Xu, Qin; Chen, Xiaojun; Li, Yuancheng; Zou, Dongling
宫颈癌
肿瘤
肿瘤免疫
发表日期：2023
文献求助 收藏

Preoperative and intraoperative assessment of myometrial invasion in patients with FIGO stage I non-endometrioid endometrial carcinoma-a large-scale, multi-center, and retrospective study

FIGO I期非子宫内膜样腺癌患者术前和术中肌层浸润评估——一项大规模、多中心回顾性研究

期刊:Diagnostic Pathology
影响因子:2.3
doi:10.1186/s13000-023-01294-z
Yang, Xiaohang; Yin, Jingjing; Fu, Yu; Shen, Yuanming; Zhang, Chuyao; Yao, Shuzhong; Xu, Congjian; Xia, Min; Lou, Ge; Liu, Jihong; Lin, Bei; Wang, Jianliu; Zhao, Weidong; Zhang, Jieqing; Cheng, Wenjun; Guo, Hongyan; Guo, Ruixia; Xue, Fengxia; Wang, Xipeng; Han, Lili; Li, Xiaomao; Zhang, Ping; Zhao, Jianguo; Li, Wenting; Dou, Yingyu; Wang, Zizhuo; Liu, Jingbo; Li, Kezhen; Chen, Gang; Sun, Chaoyang; Sun, Pengming; Lu, Weiguo; Yao, Qin
肿瘤
肿瘤免疫
发表日期：2023
文献求助 收藏

Evaluation of the prognostic value of lymphadenectomy for low-grade serous ovarian cancer: A case-control multicenter retrospective study

淋巴结切除术对低级别浆液性卵巢癌预后价值的评价：一项病例对照多中心回顾性研究

期刊:Translational Oncology
影响因子:4.1
doi:10.1016/j.tranon.2022.101476
Chen, Zhongshao; Chu, Ran; Shen, Yuanming; Yao, Qin; Chen, Jingying; Qin, Tianyu; Li, Li; Chen, Gang; Gao, Qinglei; Sun, Chaoyang; Song, Li; Li, Junting; Liu, Penglin; Pan, Xiyu; Li, Jingnan; Zhu, Xiaoying; Zhang, Li; Qiao, Xu; Ma, Ding; Kong, Beihua; Song, Kun
卵巢癌
肿瘤
肿瘤免疫
发表日期：2022
文献求助 收藏

Neoadjuvant chemotherapy for patients with international federation of gynecology and obstetrics stages IB3 and IIA2 cervical cancer: a multicenter prospective trial

对国际妇产科联盟（FIGO）分期为IB3期和IIA2期的宫颈癌患者进行新辅助化疗：一项多中心前瞻性试验

期刊:BMC Cancer
影响因子:3.4
doi:10.1186/s12885-022-10355-3
Hu, Yingjie; Han, Yingyan; Shen, Yuanming; Chen, Jing; Chen, Yaheng; Chen, Yile; Tang, Junying; Xue, Min; Hong, Li; Cheng, Wenjun; Wang, Danbo; Liang, Zhiqing; Wang, Yifeng; Zhang, Qinghua; Xing, Hui; Zhang, Yu; Yi, Cunjian; Yu, Zhiying; Chen, Youguo; Cui, Manhua; Ma, Cailing; Yang, Hongying; Li, Ruizhen; Long, Ping; Zhao, Yu; Qu, Pengpeng; Tao, Guangshi; Yang, Lihua; Wu, Sufang; Liu, Zhihua; Yang, Ping; Lv, Weiguo; Xie, Xing; Ma, Ding; Wang, Hui; Li, Kezhen
宫颈癌
肿瘤
肿瘤免疫
发表日期：2022
文献求助 收藏